• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Immune cell defenders protect us from bacteria invasion

Bioengineer by Bioengineer
April 3, 2014
in Immunology
Reading Time: 2 mins read
1
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An international team of researchers including University of Melbourne staff has identified the exact biochemical key that awakes the body’s immune cells and sends them into fight against bacteria and fungi.

Immune cell defenders protect us from bacteria invasion

Photo Credits: Jeffrey Mak University of Queensland

The patented work, published in Nature today, provides a deeper understanding of our first line of defence, and what happens when it goes wrong. It will lead to new ways of diagnosing and treating inflammatory bowel disease, peptic ulcers and even TB. It could also lead to novel protective vaccines.
The discovery is the result of national and international collaboration between the universities of Melbourne, Monash, Queensland and Cork. It also depended on access to major facilities including the Australian Synchrotron and the Bio21 Institute.

One of the leads in the research, University of Melbourne Deputy Vice-Chancellor (Research) Professor James McCluskey said it builds on work conducted last year that was acknowledged with an Australian Museum Eureka Prize in 2013.

“Our intestines, lungs and mouths are lined with mysterious immune cells that make up to ten per cent of the T cells in our immune system. Last year we showed that these cells act as sentinels against invading bacteria and fungi. Now we’ve identified the precise biochemical key that wakes up these sentries and sends them into action,” he said.

The immune cells, known as mucosal-associated invariant T cells (MAITS), initiate the immune system’s action against foreign invaders when they are exposed to vitamin B2, which is made by bacteria and fungi.

“MAIT cells are a discovery so recent that they have not even made it into the textbooks,” Professor McCluskey says. “Most doctors know nothing about them. Yet they constitute about one cell in ten of the body’s T cells and half of all the T cells in the liver.

“This is an excellent example of how our collaborative research in Australia can bring groups with expertise in different areas together to make significant advances,” Professor McCluskey said.
Dr Alexandra Corbett, a lead author on the study from the University of Melbourne said the team had unlocked a secret that will enable further investigation in the role that MAIT cells play in health and disease.

Professor Jamie Rossjohn, one of the senior authors and NHMRC Australia Fellow of Monash University,also noted the close collaborations that resulted in these findings. “To get from the first observation to today’s discovery required not just smart people but access to Melbourne’s Bio21 Institute platforms, dozens of visits to the Australian Synchrotron, and a global research network including our Irish colleagues who provided access to mutant bacterial strains.”

“All that coming together allowed us to beat our international competitors and secure the patent,” he said.

Prof David Fairlie of the Institute for Molecular Bioscience at the University of Queensland said the findings may be a valuable clue to disease pathways and new drug therapies.

Story Source:

The above story is based on materials provided by The University of Melbourne, Anne Rahilly.

Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

CK2–PRC2 Signal Drives Plant Cold Memory Epigenetics

Personalized ML Wearable Enhances Impaired Arm Function

Cancer Cells Trigger Protumor Macrophages via oxLDL

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.